ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine by Rahmani, NE, Ramachandra, N, Sahu, S, Gitego, N, Lopez, A, Pradhan, K, Bhagat, TD, Gordon-Mitchell, S, Pena, BR, Kazemi, M, Rao, K, Giricz, O, Maqbool, SB, Olea, R, Zhao, Y, Zhang, J, Dolatshad, H, Tittrea, V, Tatwavedi, D, Singh, S, Lee, J, Sun, T, Steidl, U, Shastri, A, Inoue, D, Abdel-Wahab, O, Pellagatti, A, Gavathiotis, E, Boultwood, J, Verma, A

Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells by Shastri, A, Choudhary, G, Teixeira, M, Gordon-Mitchell, S, Ramachandra, N, Bernard, L, Bhattacharyya, S, Lopez, R, Pradhan, K, Giricz, O, Ravipati, G, Wong, L, Cole, S, Bhagat, T, Feld, J, Dhar, Y, Bartenstein, M, Thiruthuvanathan, V, Wickrema, A, Ye, B, Frank, D, Pellagatti, A, Boultwood, J, Zhou, T, Kim, Y, Macleod, A, Epling-Burnette, P, Ye, M, McCoon, P, Woessner, R, Steidl, U, Will, B, Verma, A

Wnt/ß-catenin activation by epigenetically aberrant stroma drives myelodysplastic syndrome by Bhagat, T, Chen, S, Bartenstein, M, Barlowe, TS, von Ahrens, D, Choudhary, GS, Tivnan, P, Amin, E, Marcondes, AM, Sanders, MA, Hoogenboezem, RM, Kambhampati, S, Ramachandra, N, Mantzaris, I, Sukrithan, V, Laurence, R, Lopez, R, Bhagat, P, Giricz, O, Sohal, D, Wickrema, A, Yeung, CC, Gritsman, K, Aplan, PD, Hochedlinger, K, Yu, Y, Pradhan, K, Zhang, J, Greally, J, Mukherjee, S, Pellagatti, A, Boultwood, J, Will, B, Steidl, U, Raaijmakers, MH, Deeg, HJ, Kharas, MG, Verma, A